Timothy Lu
Founder bei SENTI BIOSCIENCES, INC.
Vermögen: 536 315 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Curt Herberts | M | 43 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 6 Jahre |
Michael Koeris | M | - |
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | 15 Jahre |
James Collins | M | 58 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA.
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA.
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | 10 Jahre |
Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA.
Harvard Medical School
| 11 Jahre |
Deborah Knobelman | M | 51 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 3 Jahre |
Jeffrey Lu | M | - |
Engine Biosciences Pte Ltd.
Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore.
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | 8 Jahre |
Ed Mathers Mathers | M | 64 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA.
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 Jahre |
James Weis | M | - |
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | 8 Jahre |
Susan Berland | F | 69 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 3 Jahre |
Barbara Weber | M | 67 | 7 Jahre | |
Brenda Cooperstone | M | 59 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 5 Jahre |
Daphne Teo | F | - |
Engine Biosciences Pte Ltd.
Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore.
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | 9 Jahre |
Alexis Borisy | M | 52 | 7 Jahre | |
Christopher Vann | M | 59 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | 3 Jahre |
Amy Butler | M | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | - |
Nusqe Spanton | M | - |
Provectus Algae Pty Ltd.
Provectus Algae Pty Ltd. BiotechnologyHealth Technology Provectus Algae Pty Ltd. operates as a biotech company specialising in the optimisation of Algae to produce high-value compounds for a broad range of industries and applications. It offers natural and biosynthetic production services in antibiotics, vaccines, enzymes, cosmetics, hormones, terpenes, cannabinoids products.. The company was founded by Nusqe Spanton in 2018 and is headquartered in Noosaville, Australia. | 6 Jahre |
Cheryl Cui | M | - |
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | 7 Jahre |
Devyn Smith | M | 53 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | 3 Jahre |
Malte Peters | M | 61 | 6 Jahre | |
Lee Cooper | M | - |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 4 Jahre |
Alex Kolicich | M | - |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 6 Jahre |
Alison Moore | M | 57 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | - |
Ran Geng | M | - |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 3 Jahre |
Jannik Andersen | M | - | 5 Jahre | |
Joseph F. Coughlin | M | 60 |
Massachusetts Institute of Technology
| 25 Jahre |
Jonathan Solomon | M | 47 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 7 Jahre |
Omid Farokhzad | M | 55 | 2 Jahre | |
Leo Rafael Reif | M | 73 |
Massachusetts Institute of Technology
| 25 Jahre |
Mun Tak Yang | F | 70 |
Massachusetts Institute of Technology
| 23 Jahre |
Robert Millard | M | 73 |
Massachusetts Institute of Technology
| 21 Jahre |
Susan Hockfield | M | 73 |
Massachusetts Institute of Technology
| 20 Jahre |
Emile Nuwaysir | M | 55 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | - |
Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 Jahre |
Jeffrey Massa | M | - |
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | 6 Jahre |
Jeffrey Swartz | M | - |
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | 6 Jahre |
Karah Parschauer | F | 46 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | - |
Tomaso A. Poggio | M | 75 |
Massachusetts Institute of Technology
| 22 Jahre |
Miguel Forte | M | 63 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | 6 Jahre |
Susan Nichols | F | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | - |
Robert Smith | M | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | - |
Thomas P. Chung | M | - | 2 Jahre | |
Robert Langer | M | 75 |
Massachusetts Institute of Technology
| 19 Jahre |
Mark Gorenberg | M | 69 |
Massachusetts Institute of Technology
| 23 Jahre |
Hingge Hsu | M | - |
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | - |
Bobby Gaspar | M | 60 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | 3 Jahre |
Yue Nien Tang | M | 73 |
Massachusetts Institute of Technology
| 20 Jahre |
Kanya Rajangam | M | 50 | 2 Jahre | |
Marin Soljacic | M | - |
Massachusetts Institute of Technology
| 19 Jahre |
Bob Ang | M | 49 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | 2 Jahre |
Rotem Sorek | M | - |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 9 Jahre |
Tyler Jacks | M | 63 |
Massachusetts Institute of Technology
| 17 Jahre |
Robert Woodman | M | 46 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 6 Jahre |
Shari Loessberg | F | 63 |
Massachusetts Institute of Technology
| 25 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Philip Lee | M | 43 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | 7 Jahre |
Micah Rosenbloom | M | - |
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | - |
David Miller | M | - |
Massachusetts Institute of Technology
| 21 Jahre |
Eric R. Cosman | M | - |
Massachusetts Institute of Technology
| 9 Jahre |
Michael Zhang | M | - |
Massachusetts Institute of Technology
| 11 Jahre |
Tyler Ellis | M | - |
Massachusetts Institute of Technology
| 7 Jahre |
Jose-Carlos Gutiérrez-Ramos | M | 61 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 3 Jahre |
Ishan Sachdev | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Ilya Lisansky | M | - |
Massachusetts Institute of Technology
| 4 Jahre |
Russ Spieler | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Rodrigo Canales | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Vishal Kapur | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Mira Wilczek | F | 42 |
Massachusetts Institute of Technology
| 2 Jahre |
Maiya Shur | F | - |
Massachusetts Institute of Technology
| 16 Jahre |
Alan Chhabra | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Feng Li | M | 56 |
Massachusetts Institute of Technology
| 4 Jahre |
Huan Liu | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Ted Tomlinson | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Timothy Heidel | M | - |
Massachusetts Institute of Technology
| 9 Jahre |
Larry Colagiovanni | M | - |
Massachusetts Institute of Technology
| 7 Jahre |
Carlo Tursi | M | 41 |
Massachusetts Institute of Technology
| 9 Jahre |
Ram Woo | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Vaughn Mandy | F | - |
Massachusetts Institute of Technology
| 6 Jahre |
Anibor Kragha | M | - |
Massachusetts Institute of Technology
| 2 Jahre |
Francis O'Sullivan | M | - |
Massachusetts Institute of Technology
| 2 Jahre |
Hatice Hale Özsoy Biyikli | F | 47 |
Massachusetts Institute of Technology
| 4 Jahre |
Tom Rikert | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Rachel Sheinbein | F | - |
Massachusetts Institute of Technology
| 2 Jahre |
Aaron Fyke | M | - |
Massachusetts Institute of Technology
| 2 Jahre |
Michael Speerschneider | M | - |
Massachusetts Institute of Technology
| 4 Jahre |
David Berry | M | 47 |
Massachusetts Institute of Technology
| 8 Jahre |
Alexander Taussig | M | - |
Massachusetts Institute of Technology
| 2 Jahre |
Kevin Wang | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Alice Chiang | F | - |
Massachusetts Institute of Technology
| 4 Jahre |
Young Kim | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Neena Kadaba | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Wesley Chan | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Patrick Michael McCaney | M | 43 |
Massachusetts Institute of Technology
| 5 Jahre |
Paul Carey Konigsberg | M | - |
Massachusetts Institute of Technology
| 4 Jahre |
Andy Wheeler | M | 45 |
Massachusetts Institute of Technology
| 5 Jahre |
Mia Y. Qian | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Ioannis Kymissis | M | - |
Massachusetts Institute of Technology
| 9 Jahre |
Earl Jones | M | - |
Massachusetts Institute of Technology
| 3 Jahre |
Tom Gray | M | - |
Massachusetts Institute of Technology
| 6 Jahre |
Robert Poor | M | - |
Massachusetts Institute of Technology
| 6 Jahre |
Jonathan Paul Loflin | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Nathan Hans Vantzelfde | M | - |
Massachusetts Institute of Technology
| 5 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 96 | 96,00% |
Israel | 3 | 3,00% |
Singapur | 2 | 2,00% |
Australien | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Timothy Lu
- Persönliches Netzwerk